Morningside Venture Capital Investor

Morningside Venture Capital (“Morningside”) is one of China’s earliest early-stage venture investors with around US$ 1.7 billion under management including four USD funds and one RMB fund, from the commitment of sovereign wealth funds, family offices, fund of funds, university endowments, etc. With a team that has worked together for nearly 20 years, Morningside continues discovering, supporting, and encouraging entrepreneurs, with whom there is a shared vision. The firm prides itself on not only providing insight and industry experience, but also mental and operational support. Successful investments include (NASDAQ:SOHU),
(NASDAQ:CTRP), the 9 (NASDAQ:NCTY), China Distance Education (NYSE:DL), Xunlei (NASDAQ:XNET), Phoenix New Media
(NYSE:FENG), UCWeb, YY (NASDAQ:YY), Xiaomi and more. Morningside has offices in Shanghai, Beijing and Hong Kong.

Invests into
Industry: Regenerative Medicine
Headquarters: Xuhui, Shanghai, China
Founded Date: 2008
Employees Number: 11-50
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Seed
Number Of Exits: 7

Visit Website
Register and Claim Ownership